• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study.描述银屑病患者中新冠疫情的负担：一项全球横断面研究的结果
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e636-e640. doi: 10.1111/jdv.17450. Epub 2021 Aug 19.
2
Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID).COVID-19大流行期间接受传统全身治疗、生物治疗或局部治疗的银屑病患者中SARS-CoV-2感染的患病率、风险和严重程度：一项横断面队列研究（PsoCOVID）
J Dermatolog Treat. 2023 Dec;34(1):2161297. doi: 10.1080/09546634.2022.2161297.
3
Risk of infections in psoriasis. A lesson to learn during the SARS-CoV-2 pandemic.银屑病患者的感染风险。在 SARS-CoV-2 大流行期间得到的教训。
Br J Dermatol. 2021 Jan;184(1):6. doi: 10.1111/bjd.19190. Epub 2020 Jun 15.
4
Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study.COVID-19 大流行期间银屑病患者对系统性治疗的依从性：一项多中心研究。
J Cosmet Dermatol. 2022 Jan;21(1):39-47. doi: 10.1111/jocd.14610. Epub 2021 Nov 18.
5
The impact of COVID-19 pandemic on psoriasis patients in northern Greece.新冠疫情对希腊北部银屑病患者的影响。
Dermatol Ther. 2022 Feb;35(2):e15244. doi: 10.1111/dth.15244. Epub 2021 Dec 10.
6
Drop in biological initiation for patients with psoriasis during the COVID-19 pandemic.新冠疫情期间银屑病患者生物制剂起始治疗率下降。
Br J Dermatol. 2021 Sep;185(3):671-673. doi: 10.1111/bjd.20406. Epub 2021 Jun 14.
7
Clinical management of psoriasis patients during the COVID-19 pandemic.COVID-19 大流行期间银屑病患者的临床管理。
J Dermatolog Treat. 2022 Mar;33(2):1166-1167. doi: 10.1080/09546634.2020.1781045. Epub 2020 Jun 22.
8
Prevalence, outcomes and associated factors of SARS-CoV-2 infection in psoriasis patients of Southwest China: a cross-sectional survey.西南地区银屑病患者 SARS-CoV-2 感染的流行率、结局及相关因素：一项横断面调查。
Sci Rep. 2024 Mar 15;14(1):6331. doi: 10.1038/s41598-024-54424-y.
9
A UK online survey exploring patient perspectives of remote consultations for managing psoriasis and psoriatic arthritis during the SARS-CoV-2 pandemic.一项英国在线调查，旨在探讨 SARS-CoV-2 大流行期间，患者对远程咨询管理银屑病和银屑病关节炎的看法。
Psychol Health Med. 2023 Dec;28(10):3163-3176. doi: 10.1080/13548506.2022.2104883. Epub 2022 Aug 8.
10
Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis.2019冠状病毒病大流行期间生物制剂的使用：从银屑病中吸取的经验教训。
Expert Opin Biol Ther. 2022 Dec;22(12):1521-1529. doi: 10.1080/14712598.2022.2110467. Epub 2022 Aug 8.

引用本文的文献

1
Enhanced impact of psoriasis severity on the treatment demands of patients during the COVID-19 pandemic: a cross-sectional study based on a national psoriasis registry in China.银屑病严重程度对 COVID-19 大流行期间患者治疗需求的影响增强：基于中国全国银屑病登记处的一项横断面研究。
BMJ Open. 2024 Feb 17;14(2):e079627. doi: 10.1136/bmjopen-2023-079627.
2
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries.银屑病、银屑病关节炎和中轴型脊柱关节炎患者 COVID-19 结局不良的相关特征：COVID-19 PsoProtect 和全球风湿病联盟医生报告登记处的数据。
Ann Rheum Dis. 2023 May;82(5):698-709. doi: 10.1136/ard-2022-223499. Epub 2023 Feb 14.
3
Factors associated with worsened clinical symptoms of psoriasis and disease-related quality of life during the COVID-19 lockdown: A cross-sectional study.新冠疫情封锁期间与银屑病临床症状恶化及疾病相关生活质量相关的因素：一项横断面研究。
Front Med (Lausanne). 2023 Jan 10;9:1027853. doi: 10.3389/fmed.2022.1027853. eCollection 2022.
4
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review.远程皮肤病学在2019年冠状病毒病大流行期间的作用：一项叙述性综述
Clin Cosmet Investig Dermatol. 2022 Dec 19;15:2785-2793. doi: 10.2147/CCID.S377029. eCollection 2022.
5
Effect of Lockdown Due to COVID-19 on Health and Lifestyle of Psoriasis Patients: A Web-Based Survey.2019年冠状病毒病封锁措施对银屑病患者健康和生活方式的影响：一项基于网络的调查
Indian Dermatol Online J. 2022 Sep 5;13(5):625-628. doi: 10.4103/idoj.idoj_46_22. eCollection 2022 Sep-Oct.
6
Psychopathological Symptoms Among Chronically Ill Patients During SARS-CoV-2 Pandemic in Poland.波兰新冠疫情期间慢性病患者的精神病理症状
Psychol Res Behav Manag. 2022 Sep 16;15:2659-2669. doi: 10.2147/PRBM.S362918. eCollection 2022.
7
The Effect of COVID-19 on the Perioperative Course of Acute Coronary Syndrome in Poland: The Estimation of Perioperative Prognosis and Neural Network Analysis in 243,515 Cases from 2020 to 2021.2020年至2021年期间243,515例病例中，新型冠状病毒肺炎对波兰急性冠状动脉综合征围手术期病程的影响：围手术期预后评估及神经网络分析
J Clin Med. 2022 Sep 14;11(18):5394. doi: 10.3390/jcm11185394.
8
Impact of the COVID-19 Pandemic on the Mental Health and Quality of Life of Patients with Psoriasis in Tertiary Care; A One-year Follow-up.新冠疫情对三级医疗中银屑病患者心理健康和生活质量的影响；一年随访
Acta Derm Venereol. 2022 Nov 14;102:adv00814. doi: 10.2340/actadv.v102.2464.
9
The effect of the Covid-19 pandemic on illness perceptions of psoriasis and the role of depression: Findings from a cross-sectional study.新冠疫情对银屑病疾病认知的影响及抑郁的作用：一项横断面研究的结果
Skin Health Dis. 2022 Jul 3;2(3):e145. doi: 10.1002/ski2.145. eCollection 2022 Sep.
10
The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.2019年冠状病毒病大流行对皮肤病的影响：一项新颖的全面综述
Dermatopathology (Basel). 2022 Jun 29;9(3):212-243. doi: 10.3390/dermatopathology9030027.

本文引用的文献

1
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.在 COVID-19 大流行期间，患有炎症性皮肤和关节疾病的人群的风险缓解行为因治疗类型而异：一项横断面患者调查。
Br J Dermatol. 2021 Jul;185(1):80-90. doi: 10.1111/bjd.19755. Epub 2021 Mar 9.
2
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.与银屑病患者 COVID-19 不良结局相关的因素：一项基于全球注册研究的分析。
J Allergy Clin Immunol. 2021 Jan;147(1):60-71. doi: 10.1016/j.jaci.2020.10.007. Epub 2020 Oct 16.
3
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.国家银屑病基金会 COVID-19 工作组关于大流行期间银屑病管理的指南：第 1 版。
J Am Acad Dermatol. 2020 Dec;83(6):1704-1716. doi: 10.1016/j.jaad.2020.09.001. Epub 2020 Sep 4.
4
Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population.新冠疫情之前及期间的心理健康状况：一项针对英国人群的纵向概率抽样调查
Lancet Psychiatry. 2020 Oct;7(10):883-892. doi: 10.1016/S2215-0366(20)30308-4. Epub 2020 Jul 21.
5
The Invisible Epidemic: Neglected Chronic Disease Management During COVID-19.隐形流行病：新冠疫情期间被忽视的慢性病管理
J Gen Intern Med. 2020 Sep;35(9):2816-2817. doi: 10.1007/s11606-020-06025-4. Epub 2020 Jul 14.
6
Mortality and Morbidity: The Measure of a Pandemic.死亡率与发病率：大流行的衡量标准
JAMA. 2020 Aug 4;324(5):458-459. doi: 10.1001/jama.2020.11761.
7
Mental Health and the Covid-19 Pandemic.心理健康与新冠疫情
N Engl J Med. 2020 Aug 6;383(6):510-512. doi: 10.1056/NEJMp2008017. Epub 2020 Apr 13.
8
Chronic Conditions and Behavioural Change Approaches to Medication Adherence: Rethinking Clinical Guidance and Recommendations.慢性病与促进药物依从性的行为改变方法：重新思考临床指南与建议
Patient Prefer Adherence. 2020 Mar 12;14:581-586. doi: 10.2147/PPA.S239916. eCollection 2020.
9
Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting.银屑病患者焦虑和抑郁的筛查：在三级转诊环境中的横断面研究。
Br J Dermatol. 2017 Apr;176(4):1028-1034. doi: 10.1111/bjd.14833. Epub 2016 Dec 29.
10
An ultra-brief screening scale for anxiety and depression: the PHQ-4.一个用于焦虑和抑郁的超简短筛查量表：PHQ-4。
Psychosomatics. 2009 Nov-Dec;50(6):613-21. doi: 10.1176/appi.psy.50.6.613.

Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study.

作者信息

Mahil S K, Yates M, Yiu Z Z N, Langan S M, Tsakok T, Dand N, Mason K J, McAteer H, Meynell F, Coker B, Vincent A, Urmston D, Vesty A, Kelly J, Lancelot C, Moorhead L, Bachelez H, Capon F, Contreras C R, De La Cruz C, Di Meglio P, Gisondi P, Jullien D, Lambert J, Naldi L, Norton S, Puig L, Spuls P, Torres T, Warren R B, Waweru H, Weinman J, Brown M A, Galloway J B, Griffiths C M, Barker J N, Smith C H

机构信息

St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.

NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.

出版信息

J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e636-e640. doi: 10.1111/jdv.17450. Epub 2021 Aug 19.

DOI:10.1111/jdv.17450
PMID:34145643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8447018/
Abstract
摘要